Official Gene Symbol | Other Aliases |
---|---|
TP53BP1 | N/A |
Sequence Length (AA) | Molecular Weight (Da) |
---|---|
1972 | 213574 |
Protein Name |
---|
Tumor suppressor p53-binding protein 1 |
Sources | |
---|---|
UniProt PhosphoSitePlus ® GeneCards |
Human Protein Atlas |
10 | 20 | 30 | 40 | 50 |
MDPTGSQLDS | DFSQQDTPCL | IIEDSQPESQ | VLEDDSGSHF | SMLSRHLPNL |
60 | 70 | 80 | 90 | 100 |
QTHKENPVLD | VVSNPEQTAG | EERGDGNSGF | NEHLKENKVA | DPVDSSNLDT |
110 | 120 | 130 | 140 | 150 |
CGSISQVIEQ | LPQPNRTSSV | LGMSVESAPA | VEEEKGEELE | QKEKEKEEDT |
160 | 170 | 180 | 190 | 200 |
SGNTTHSLGA | EDTASSQLGF | GVLELSQSQD | VEENTVPYEV | DKEQLQSVTT |
210 | 220 | 230 | 240 | 250 |
NSGYTRLSDV | DANTAIKHEE | QSNEDIPIAE | QSSKDIPVTA | QPSKDVHVVK |
260 | 270 | 280 | 290 | 300 |
EQNPPPARSE | DMPFSPKASV | AAMEAKEQLS | AQELMESGLQ | IQKSPEPEVL |
310 | 320 | 330 | 340 | 350 |
STQEDLFDQS | NKTVSSDGCS | TPSREEGGCS | LASTPATTLH | LLQLSGQRSL |
360 | 370 | 380 | 390 | 400 |
VQDSLSTNSS | DLVAPSPDAF | RSTPFIVPSS | PTEQEGRQDK | PMDTSVLSEE |
410 | 420 | 430 | 440 | 450 |
GGEPFQKKLQ | SGEPVELENP | PLLPESTVSP | QASTPISQST | PVFPPGSLPI |
460 | 470 | 480 | 490 | 500 |
PSQPQFSHDI | FIPSPSLEEQ | SNDGKKDGDM | HSSSLTVECS | KTSEIEPKNS |
510 | 520 | 530 | 540 | 550 |
PEDLGLSLTG | DSCKLMLSTS | EYSQSPKMES | LSSHRIDEDG | ENTQIEDTEP |
560 | 570 | 580 | 590 | 600 |
MSPVLNSKFV | PAENDSILMN | PAQDGEVQLS | QNDDKTKGDD | TDTRDDISIL |
610 | 620 | 630 | 640 | 650 |
ATGCKGREET | VAEDVCIDLT | CDSGSQAVPS | PATRSEALSS | VLDQEEAMEI |
660 | 670 | 680 | 690 | 700 |
KEHHPEEGSS | GSEVEEIPET | PCESQGEELK | EENMESVPLH | LSLTETQSQG |
710 | 720 | 730 | 740 | 750 |
LCLQKEMPKK | ECSEAMEVET | SVISIDSPQK | LAILDQELEH | KEQEAWEEAT |
760 | 770 | 780 | 790 | 800 |
SEDSSVVIVD | VKEPSPRVDV | SCEPLEGVEK | CSDSQSWEDI | APEIEPCAEN |
810 | 820 | 830 | 840 | 850 |
RLDTKEEKSV | EYEGDLKSGT | AETEPVEQDS | SQPSLPLVRA | DDPLRLDQEL |
860 | 870 | 880 | 890 | 900 |
QQPQTQEKTS | NSLTEDSKMA | NAKQLSSDAE | AQKLGKPSAH | ASQSFCESSS |
910 | 920 | 930 | 940 | 950 |
ETPFHFTLPK | EGDIIPPLTG | ATPPLIGHLK | LEPKRHSTPI | GISNYPESTI |
960 | 970 | 980 | 990 | 1000 |
ATSDVMSESM | VETHDPILGS | GKGDSGAAPD | VDDKLCLRMK | LVSPETEASE |
1010 | 1020 | 1030 | 1040 | 1050 |
ESLQFNLEKP | ATGERKNGST | AVAESVASPQ | KTMSVLSCIC | EARQENEARS |
1060 | 1070 | 1080 | 1090 | 1100 |
EDPPTTPIRG | NLLHFPSSQG | EEEKEKLEGD | HTIRQSQQPM | KPISPVKDPV |
1110 | 1120 | 1130 | 1140 | 1150 |
SPASQKMVIQ | GPSSPQGEAM | VTDVLEDQKE | GRSTNKENPS | KALIERPSQN |
1160 | 1170 | 1180 | 1190 | 1200 |
NIGIQTMECS | LRVPETVSAA | TQTIKNVCEQ | GTSTVDQNFG | KQDATVQTER |
1210 | 1220 | 1230 | 1240 | 1250 |
GSGEKPVSAP | GDDTESLHSQ | GEEEFDMPQP | PHGHVLHRHM | RTIREVRTLV |
1260 | 1270 | 1280 | 1290 | 1300 |
TRVITDVYYV | DGTEVERKVT | EETEEPIVEC | QECETEVSPS | QTGGSSGDLG |
1310 | 1320 | 1330 | 1340 | 1350 |
DISSFSSKAS | SLHRTSSGTS | LSAMHSSGSS | GKGAGPLRGK | TSGTEPADFA |
1360 | 1370 | 1380 | 1390 | 1400 |
LPSSRGGPGK | LSPRKGVSQT | GTPVCEEDGD | AGLGIRQGGK | APVTPRGRGR |
1410 | 1420 | 1430 | 1440 | 1450 |
RGRPPSRTTG | TRETAVPGPL | GIEDISPNLS | PDDKSFSRVV | PRVPDSTRRT |
1460 | 1470 | 1480 | 1490 | 1500 |
DVGAGALRRS | DSPEIPFQAA | AGPSDGLDAS | SPGNSFVGLR | VVAKWSSNGY |
1510 | 1520 | 1530 | 1540 | 1550 |
FYSGKITRDV | GAGKYKLLFD | DGYECDVLGK | DILLCDPIPL | DTEVTALSED |
1560 | 1570 | 1580 | 1590 | 1600 |
EYFSAGVVKG | HRKESGELYY | SIEKEGQRKW | YKRMAVILSL | EQGNRLREQY |
1610 | 1620 | 1630 | 1640 | 1650 |
GLGPYEAVTP | LTKAADISLD | NLVEGKRKRR | SNVSSPATPT | ASSSSSTTPT |
1660 | 1670 | 1680 | 1690 | 1700 |
RKITESPRAS | MGVLSGKRKL | ITSEEERSPA | KRGRKSATVK | PGAVGAGEFV |
1710 | 1720 | 1730 | 1740 | 1750 |
SPCESGDNTG | EPSALEEQRG | PLPLNKTLFL | GYAFLLTMAT | TSDKLASRSK |
1760 | 1770 | 1780 | 1790 | 1800 |
LPDGPTGSSE | EEEEFLEIPP | FNKQYTESQL | RAGAGYILED | FNEAQCNTAY |
1810 | 1820 | 1830 | 1840 | 1850 |
QCLLIADQHC | RTRKYFLCLA | SGIPCVSHVW | VHDSCHANQL | QNYRNYLLPA |
1860 | 1870 | 1880 | 1890 | 1900 |
GYSLEEQRIL | DWQPRENPFQ | NLKVLLVSDQ | QQNFLELWSE | ILMTGGAASV |
1910 | 1920 | 1930 | 1940 | 1950 |
KQHHSSAHNK | DIALGVFDVV | VTDPSCPASV | LKCAEALQLP | VVSQEWVIQC |
1960 | 1970 | 1972 | ||
LIVGERIGFK | QHPKYKHDYV | SH |
Data source: UniProt
Uniprot Database Entry PhosphoSitePlus ®
loading
Data source: Panorama
View Details (opens in a new window)
Abelin, et al. Mol Cell Proteomics. 2016 May;15(5):1622-41. doi: 10.1074/mcp.M116.058354. Epub 2016 Feb 24. PMID:26912667
Data source: Panorama
Johns Hopkins University-I
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y6-98 (1+) | 9 | 7.5 | 4.8 | 9.5 | 8.2 | 11.6 | 13.1 | 11.1 | 12.6 | 15 | 15 | 15 |
y5-98 (1+) | 9.7 | 7.3 | 5.2 | 8.5 | 8.5 | 10.9 | 12.9 | 11.2 | 12.1 | 15 | 15 | 15 |
y4-98 (1+) | 7 | 3.9 | 6.3 | 7.4 | 5.2 | 15.2 | 10.2 | 6.5 | 16.5 | 15 | 15 | 15 |
sum | 5.1 | 3.6 | 4.4 | 6.1 | 5.3 | 11.7 | 8 | 6.4 | 12.5 | 15 | 15 | 15 |
Data source: Panorama
View Details (opens in a new window)
Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. Whiteaker JR, Wang T, Zhao L, Schoenherr RM, Kennedy JJ, Voytovich U, Ivey RG, Huang D, Lin C, Colantonio S, Caceres TW, Roberts RR, Knotts JG, Kaczmarczyk JA, Blonder J, Reading JJ, Richardson CW, Hewitt SM, Garcia-Buntley SS, Bocik W, Hiltke T, Rodriguez H, Harrington EA, Barrett JC, Lombardi B, Marco-Casanova P, Pierce AJ, Paulovich AG. Cancers (Basel). 2021 Jul 30;13(15):3843. doi: 10.3390/cancers13153843. PMID: 34359745
Data source: Panorama
Johns Hopkins University-I
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y7 (1+) | 64 | 19.1 | 13.5 | 59.2 | 24.9 | 18.3 | 87.2 | 31.4 | 22.7 | 15 | 27 | 15 |
y6 (1+) | 31.5 | 17.3 | 11.8 | 58.5 | 18.9 | 13.7 | 66.4 | 25.6 | 18.1 | 15 | 27 | 15 |
y9 (2+) | 17.5 | 14.7 | 7.1 | 18.5 | 15.4 | 11 | 25.5 | 21.3 | 13.1 | 15 | 27 | 15 |
b10 (1+) | 85.1 | 25.5 | 21.5 | 68.5 | 24.6 | 27.7 | 109.2 | 35.4 | 35.1 | 15 | 27 | 15 |
b13 (2+) | 58.6 | 17.4 | 24.7 | 45.7 | 23 | 27.9 | 74.3 | 28.8 | 37.3 | 15 | 27 | 15 |
y9 (1+) | 18.4 | 8.7 | 9.9 | 22.6 | 15.4 | 16.1 | 29.1 | 17.7 | 18.9 | 15 | 27 | 15 |
sum | 11.9 | 7.6 | 6.5 | 10.1 | 13 | 10.2 | 15.6 | 15.1 | 12.1 | 15 | 27 | 15 |
Data source: Panorama
View Details (opens in a new window)
Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. Whiteaker JR, Wang T, Zhao L, Schoenherr RM, Kennedy JJ, Voytovich U, Ivey RG, Huang D, Lin C, Colantonio S, Caceres TW, Roberts RR, Knotts JG, Kaczmarczyk JA, Blonder J, Reading JJ, Richardson CW, Hewitt SM, Garcia-Buntley SS, Bocik W, Hiltke T, Rodriguez H, Harrington EA, Barrett JC, Lombardi B, Marco-Casanova P, Pierce AJ, Paulovich AG. Cancers (Basel). 2021 Jul 30;13(15):3843. doi: 10.3390/cancers13153843. PMID: 34359745
Data source: Panorama
Johns Hopkins University-I
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y10 (1+) | 112.4 | 88.3 | 43.8 | 137.4 | 79.9 | 70.8 | 177.5 | 119.1 | 83.3 | 8 | 21 | 10 |
y9 (1+) | 54.8 | 56.9 | 29 | 52.3 | 32.2 | 37 | 75.8 | 65.4 | 47 | 15 | 27 | 15 |
y7 (1+) | 68.3 | 51.7 | 60.2 | 124.6 | 56.1 | 85.7 | 142.1 | 76.3 | 104.7 | 14 | 27 | 15 |
y6 (1+) | 63.8 | 65 | 48.5 | 107.5 | 55 | 76.4 | 125 | 85.1 | 90.5 | 15 | 27 | 15 |
y9 (2+) | 78.6 | 75.9 | 47.3 | 108.6 | 66.3 | 53.7 | 134.1 | 100.8 | 71.6 | 15 | 27 | 15 |
b10 (1+) | 162.6 | 67.6 | 51 | 144.9 | 54.2 | 66.5 | 217.8 | 86.6 | 83.8 | 10 | 23 | 9 |
b13 (2+) | 76.7 | 71.5 | 71.2 | 100.1 | 64.4 | 93 | 126.1 | 96.2 | 117.1 | 15 | 26 | 15 |
b21-98 (3+) | 67 | 78.2 | 49.1 | 72.6 | 70.9 | 73.5 | 98.8 | 105.6 | 88.4 | 14 | 27 | 14 |
sum | 39 | 23.2 | 17.9 | 56.8 | 20.7 | 33.6 | 68.9 | 31.1 | 38.1 | 15 | 27 | 15 |
Data source: Panorama
View Details (opens in a new window)
Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. Whiteaker JR, Wang T, Zhao L, Schoenherr RM, Kennedy JJ, Voytovich U, Ivey RG, Huang D, Lin C, Colantonio S, Caceres TW, Roberts RR, Knotts JG, Kaczmarczyk JA, Blonder J, Reading JJ, Richardson CW, Hewitt SM, Garcia-Buntley SS, Bocik W, Hiltke T, Rodriguez H, Harrington EA, Barrett JC, Lombardi B, Marco-Casanova P, Pierce AJ, Paulovich AG. Cancers (Basel). 2021 Jul 30;13(15):3843. doi: 10.3390/cancers13153843. PMID: 34359745
Data source: Panorama
Johns Hopkins University-I
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y9-98 (1+) | 66 | 27.1 | 9.6 | 69.9 | 34.6 | 16.9 | 96.1 | 43.9 | 19.4 | 15 | 27 | 15 |
y6 (1+) | 92.8 | 25.6 | 27.2 | 65.8 | 27.8 | 29.9 | 113.8 | 37.8 | 40.4 | 15 | 27 | 15 |
y9 (2+) | 44.4 | 16.4 | 12.9 | 41.8 | 17.2 | 19.3 | 61 | 23.8 | 23.2 | 15 | 27 | 15 |
b9 (1+) | 107.6 | 42.4 | 33.3 | 87.8 | 54.8 | 48.3 | 138.9 | 69.3 | 58.7 | 15 | 27 | 15 |
b10 (1+) | 110.2 | 37 | 30.7 | 146.7 | 34.1 | 25.3 | 183.5 | 50.3 | 39.8 | 15 | 27 | 15 |
b13 (2+) | 94.2 | 46.7 | 40 | 85.9 | 52.9 | 49.8 | 127.5 | 70.6 | 63.9 | 15 | 27 | 15 |
sum | 24.3 | 12.6 | 10.5 | 22.5 | 16.6 | 18.1 | 33.1 | 20.8 | 20.9 | 15 | 27 | 15 |
Data source: Panorama
View Details (opens in a new window)
Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. Whiteaker JR, Wang T, Zhao L, Schoenherr RM, Kennedy JJ, Voytovich U, Ivey RG, Huang D, Lin C, Colantonio S, Caceres TW, Roberts RR, Knotts JG, Kaczmarczyk JA, Blonder J, Reading JJ, Richardson CW, Hewitt SM, Garcia-Buntley SS, Bocik W, Hiltke T, Rodriguez H, Harrington EA, Barrett JC, Lombardi B, Marco-Casanova P, Pierce AJ, Paulovich AG. Cancers (Basel). 2021 Jul 30;13(15):3843. doi: 10.3390/cancers13153843. PMID: 34359745
Data source: Panorama
Johns Hopkins University-I
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y9 (1+) | 146.1 | 75 | 36.2 | 187.1 | 113.8 | 53.6 | 237.4 | 136.3 | 64.7 | 13 | 22 | 14 |
y9-98 (1+) | 137.8 | 131.3 | 43.2 | 165.6 | 102.4 | 80.1 | 215.4 | 166.5 | 91 | 11 | 18 | 11 |
y7 (1+) | 103 | 151 | 47.5 | 105.6 | 119 | 74.2 | 147.5 | 192.3 | 88.1 | 13 | 24 | 15 |
y6 (1+) | 74 | 75.8 | 44.4 | 150.3 | 90.6 | 59.3 | 167.5 | 118.1 | 74.1 | 14 | 25 | 13 |
y9 (2+) | 98 | 82.1 | 55.9 | 134.5 | 109.6 | 53 | 166.4 | 136.9 | 77 | 13 | 25 | 15 |
b5 (1+) | 141.4 | 117.9 | 61 | 114.4 | 96.5 | 67.6 | 181.9 | 152.4 | 91.1 | 5 | 9 | 14 |
b13 (2+) | 96.7 | 122.6 | 40.4 | 91 | 131.3 | 67.9 | 132.8 | 179.6 | 79 | 12 | 24 | 15 |
sum | 59.1 | 41.1 | 22.5 | 54.5 | 47.7 | 44 | 80.4 | 63 | 49.4 | 15 | 27 | 15 |
Data source: Panorama
View Details (opens in a new window)
Kennedy JJ, Yan P, Zhao L, Ivey RG, Voytovich U, Moore HD, Lin C, Pogosova-Agadjanyan EL, Stirewalt DL, Reding KW, Whiteaker JR, Paulovich AG. Immobilized metal affinity chromatography coupled to multiple reaction monitoring enables reproducible quantification of phospho-signaling. Molecular and Cellular Proteomics. mcp.O115.054940
Data source: Panorama
Johns Hopkins University-I
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y14 (2+) | 52.9 | 21.7 | 10.2 | 59.2 | 21.7 | 11.4 | 79.4 | 30.7 | 15.3 | 15 | 24 | 15 |
y8 (1+) | 60.1 | 17.9 | 10.6 | 73.2 | 18.9 | 14 | 94.7 | 26 | 17.6 | 15 | 24 | 15 |
y10 (1+) | 40.8 | 17.2 | 8.1 | 43.9 | 16.6 | 9 | 59.9 | 23.9 | 12.1 | 15 | 24 | 15 |
sum | 19.3 | 14.2 | 7.1 | 26.3 | 15.4 | 10.1 | 32.6 | 20.9 | 12.3 | 15 | 24 | 15 |
Data source: Panorama
View Details (opens in a new window)
Kennedy JJ, Yan P, Zhao L, Ivey RG, Voytovich U, Moore HD, Lin C, Pogosova-Agadjanyan EL, Stirewalt DL, Reding KW, Whiteaker JR, Paulovich AG. Immobilized metal affinity chromatography coupled to multiple reaction monitoring enables reproducible quantification of phospho-signaling. Molecular and Cellular Proteomics. mcp.O115.054940
Data source: Panorama
Johns Hopkins University-I
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y14 (2+) | 31.5 | 43 | 35.7 | 31.2 | 31.5 | 55.8 | 44.3 | 53.3 | 66.2 | 12 | 23 | 15 |
y15 (2+) | 33 | 12.3 | 14.1 | 41.6 | 16.6 | 18.3 | 53.1 | 20.7 | 23.1 | 12 | 23 | 15 |
y7 (1+) | 35 | 15.1 | 5.7 | 34.6 | 19.5 | 12.7 | 49.2 | 24.7 | 13.9 | 12 | 23 | 15 |
sum | 23.6 | 13.3 | 4.8 | 26 | 16.2 | 12.6 | 35.1 | 21 | 13.5 | 12 | 23 | 15 |
Data source: Panorama
Data source: Panorama
Johns Hopkins University-I
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y10 (1+) | 19.3 | 4.1 | 4.6 | 17.5 | 7.4 | 5.6 | 26.1 | 8.5 | 7.2 | 15 | 15 | 15 |
y9 (1+) | 11.7 | 6.9 | 5.9 | 12.7 | 8.8 | 5.9 | 17.3 | 11.2 | 8.3 | 15 | 15 | 15 |
y8 (1+) | 12.4 | 4.1 | 5.1 | 12 | 8.7 | 7.7 | 17.3 | 9.6 | 9.2 | 15 | 15 | 15 |
sum | 9.8 | 4.5 | 4.5 | 7.8 | 7.5 | 5.1 | 12.5 | 8.7 | 6.8 | 15 | 15 | 15 |
Data source: Panorama
Data source: Panorama
Johns Hopkins University-I
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y10 (1+) | 17.6 | 7.2 | 7.1 | 20.4 | 11.8 | 7.1 | 26.9 | 13.8 | 10 | 15 | 15 | 15 |
y9 (1+) | 12 | 5.6 | 5.7 | 13.2 | 9.1 | 6 | 17.8 | 10.7 | 8.3 | 15 | 15 | 15 |
y7 (1+) | 30.6 | 5.7 | 9.6 | 26.3 | 12.8 | 10.1 | 40.3 | 14 | 13.9 | 15 | 15 | 15 |
sum | 11.5 | 5.4 | 5.5 | 11.4 | 9.3 | 5.6 | 16.2 | 10.8 | 7.8 | 15 | 15 | 15 |
Comments